[#DIV28SUPER] Johns Hopkins Postdoctoral Position Available in field of OUD

Dear colleagues,

The Johns Hopkins University School of Medicine invites applications for postdoctoral research fellowships at the Behavioral Pharmacology Research Unit (BPRU) within the Department of Psychiatry and Behavioral Sciences. Fellows receive research training in the clinical pharmacology of substance use including human laboratory studies and clinical treatment trials. Fellows benefit from experienced faculty and a NIDA-funded T32 training grant with a productive 40-year history and over 130 graduates. Fellows work closely with faculty mentors to gain practical research experience and develop as productive independent scholars.

Areas of interest: This postdoctoral fellow will work with Drs Kelly Dunn and Andrew Huhn in the area of opioid use disorder. Fellows will have the opportunity to gain experience in clinical trials, human laboratory drug administration studies, and treatment outcomes studies. Research in the Dunn and Huhn labs cover a broad range of topics, including the treatment of opioid use disorder, opioid withdrawal, sleep, emotional processes, chronic and acute pain, and abuse liability of opioids and other medications. These studies employ diverse methodology including ecological momentary assessments, sleep electroencephalography (EEG), ambulatory monitoring of daily activity and sleep, quantitative sensory testing of pain, genetics, and biological assays of stress and inflammation. Prospective candidates should have a strong interest in medication studies and/or utilizing advanced statistical analyses (e.g., machine learning). The selected candidate would also have the opportunity to collaborate with multiple BPRU faculty across different projects.

Eligibility: Eligible applicants must be a U.S. citizen or permanent resident and have completed doctoral degree requirements (e.g., PhD, MD, DO, PsyD) prior to starting at BPRU. Many backgrounds are appropriate, including experimental or clinical psychology, pharmacology, psychiatry or other medicine, neuroscience, nursing, public health, and social work. Prior experience with human or nonhuman research is appropriate. The BPRU is particularly interested in candidates who can contribute to the diversity and excellence of our research program. Applications from persons with disabilities, protected veterans, and persons underrepresented in science are strongly encouraged.

Start date: Flexible.

To Apply please send your CV and letter of interest to Kelly E. Dunn, Ph.D, MBA (kdunn9@jhmi.edu) and Andrew S. Huhn, Ph.D., MBA (ahuhn1@jhmi.edu)

Faculty: https://www.hopkinsmedicine.org/psychiatry/research/BPRU/expert_team.html and Program Website: https://www.hopkinsmedicine.org/psychiatry/research/BPRU/

Johns Hopkins University is an equal opportunity/affirmative action employer committed to recruiting, supporting, and fostering a diverse community.

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

[#DIV28SUPER] ACC Nominations

Dear Colleagues-

Please find attached the 2021 Call for Nominations to the APA Advocacy Coordinating Committee.

The announcement can also be accessed through this URL:

https://www.apaservices.org/advocacy/governance/nominations-advocacy-coordinating-committee

-Bill Stoops.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky

Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science

Clinical Research Support Office

Associate Director for Clinical Research

Substance Use Priority Research Area

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

Re: [#DIV28SUPER] In Memoriam: Dr. Martin Iguchi, Ph.D.

Thanks, Maxine, for a lovely personal tribute.  I’m so sorry about this loss.

Wilson

 

From: Kelly Dunn <kdunn9@JHMI.EDU>
Sent: Thursday, June 10, 2021 11:53 AM
To: DIV28SUPER@LISTS.APA.ORG
Subject: [#DIV28SUPER] In Memoriam: Dr. Martin Iguchi, Ph.D.

 

Dear Colleagues,

 

I am writing with the sad news that Dr. Martin Iguchi, Ph.D., a pillar in our Division and scientific community, passed away on Saturday June 5, 2021. Dr. Iguchi earned his PhD in experimental psychology from Boston University in 1986 and established himself as a major leader in our field over the past several decades. As his CV demonstrates, he led research in several impactful areas that included HIV research, treatment access for minority individuals, and expansion of care for persons with OUD and alcohol. His collective work spanned the spectrum from understanding mechanistic foundations of substance use to treatment implementation. Despite his strong science, Dr. Iguchi may have been equally well-known for being an exemplary scientific citizen. He has served in every capacity, including study sections, committee memberships, board of director and advisory board positions, and editorial roles. He also shared his wisdom through teaching, mentoring numerous junior scientists in predoctoral, post-doctoral, and early career roles, and his service on dissertation and promotion committees, earning awards for his prowess in this area. In recent years he had established himself as a policy leader who could be relied upon to help advocate for the advancement of research and care for persons with substance use disorder, producing a lasting legacy on our field.  

 

Dr. Iguchi was particularly committed to the work of APA and Division 28. He achieved Fellow status of our division in 2000 and was a fellow of Divisions 6, 9, and 50 as well.  He was the 2004 Division 28 Convention Chair, Member-at-Large for Division 50, member of the Board of Professional Affairs, member of an APA task force to make changes to the convention that would appeal to scientists, a member of the Board of Scientific Affairs, on the Health Disparities Steering Committee, on the Committee of Psychology of AIDS, and on the Board for the Advancement of Psychology in the Public Practice.  As a result of his profound contributions to the field, Dr. Iguchi was awarded an APA Presidential Citation in 2019 (a prestigious honor reserved for only a small number of outstanding psychologists).  

 

Dr. Iguchi was well-known at APA Consolidated Meetings as well as other professional organizational meetings, and always approached people with a smile and kind words. His welcoming demeanor and breadth of expertise made him an ideal ambassador for our science and his veracity in advocating for the use of science to advance public policy no doubt benefited countless numbers of patients and scientists. He represents the type of scientist we all aspire to become and will be dearly missed.  

 

More about his work is available here https://www.rand.org/about/people/i/iguchi_martin_y.html  and his APA Presidential citation is available here: https://www.apa.org/about/governance/president/citation/martin-iguchi

 

Please also see the following thoughts from our Divisional member and past President Dr. Maxine Stitzer

 

"I first met Martin Iguchi in the late 80’s when he worked as a Postdoc at the BPRU on studies conducted in our methadone research clinic.  Over the years, he became a friend as well as a valued colleague and he will be sorely missed in both roles. Martin was enthusiastic, passionate, and optimistic about life.  He was diagnosed with metastatic colon cancer 5 years ago, and at that time, given a prognosis of one year.  He looked at the life he loved and chose to forge ahead.  He loved his work in addictions research and he loved his wife, Beth and their children Benjamin and Sarah.  He chose to pursue his research projects vigorously until he physically could no longer, contributing his wisdom to the important public health issues of the day and the research that underpins sensible policy.   

 

Maybe it was his positive attitude- these things are unknowable- but Martin beat the odds and stayed in this world, fighting his disease, for 5 long years after that first bleak prognosis.  We called him the “medical miracle”.  In the end, of course, the cancer won.  But Martin’s attitude was truly admirable.  He accepted his diagnosis and was forthright with friends about the process of the illness and its treatment, all the while continuing to work and to enjoy his life.   

 

Meanwhile, Beth was beside him offering her support.  They were a team, Martin and Beth, and I know it’s hard for her to imagine her life without him.  Because I grew up in Los Angeles where Duncan and I visited frequently, we would always stop to see Martin and Beth in Santa Monica and bask in their gracious hospitality.  Nothing fancy mind you, but they were always pleased to see us and to share a meal in the house or the backyard.  I have a fond memory of taking my elderly mother with us on one or two of these visits and seeing her entertained by Martin and Beth’s friendly company.  Our world will be a lesser place without Martin; we will greatly miss his enthusiasm, energy, passion, wisdom and friendship.  Farewell, dear friend and colleague."- Dr. Maxine Stitzer

 

 

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

 

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

Re: [#DIV28SUPER] In Memoriam: Dr. Martin Iguchi, Ph.D.

Dear Colleagues,

I am writing with the sad news that Dr. Martin Iguchi, Ph.D., a pillar in our Division and scientific community, passed away on Saturday June 5, 2021. Dr. Iguchi earned his PhD in experimental psychology from Boston University in 1986 and established himself as a major leader in our field over the past several decades. As his CV demonstrates, he led research in several impactful areas that included HIV research, treatment access for minority individuals, and expansion of care for persons with OUD and alcohol. His collective work spanned the spectrum from understanding mechanistic foundations of substance use to treatment implementation. Despite his strong science, Dr. Iguchi may have been equally well-known for being an exemplary scientific citizen. He has served in every capacity, including study sections, committee memberships, board of director and advisory board positions, and editorial roles. He also shared his wisdom through teaching, mentoring numerous junior scientists in predoctoral, post-doctoral, and early career roles, and his service on dissertation and promotion committees, earning awards for his prowess in this area. In recent years he had established himself as a policy leader who could be relied upon to help advocate for the advancement of research and care for persons with substance use disorder, producing a lasting legacy on our field.  

 

Dr. Iguchi was particularly committed to the work of APA and Division 28. He achieved Fellow status of our division in 2000 and was a fellow of Divisions 6, 9, and 50 as well.  He was the 2004 Division 28 Convention Chair, Member-at-Large for Division 50, member of the Board of Professional Affairs, member of an APA task force to make changes to the convention that would appeal to scientists, a member of the Board of Scientific Affairs, on the Health Disparities Steering Committee, on the Committee of Psychology of AIDS, and on the Board for the Advancement of Psychology in the Public Practice.  As a result of his profound contributions to the field, Dr. Iguchi was awarded an APA Presidential Citation in 2019 (a prestigious honor reserved for only a small number of outstanding psychologists).  

 

Dr. Iguchi was well-known at APA Consolidated Meetings as well as other professional organizational meetings, and always approached people with a smile and kind words. His welcoming demeanor and breadth of expertise made him an ideal ambassador for our science and his veracity in advocating for the use of science to advance public policy no doubt benefited countless numbers of patients and scientists. He represents the type of scientist we all aspire to become and will be dearly missed.  

More about his work is available here https://www.rand.org/about/people/i/iguchi_martin_y.html  and his APA Presidential citation is available here: https://www.apa.org/about/governance/president/citation/martin-iguchi

Please also see the following thoughts from our Divisional member and past President Dr. Maxine Stitzer

"I first met Martin Iguchi in the late 80's when he worked as a Postdoc at the BPRU on studies conducted in our methadone research clinic.  Over the years, he became a friend as well as a valued colleague and he will be sorely missed in both roles. Martin was enthusiastic, passionate, and optimistic about life.  He was diagnosed with metastatic colon cancer 5 years ago, and at that time, given a prognosis of one year.  He looked at the life he loved and chose to forge ahead.  He loved his work in addictions research and he loved his wife, Beth and their children Benjamin and Sarah.  He chose to pursue his research projects vigorously until he physically could no longer, contributing his wisdom to the important public health issues of the day and the research that underpins sensible policy.   

 

Maybe it was his positive attitude- these things are unknowable- but Martin beat the odds and stayed in this world, fighting his disease, for 5 long years after that first bleak prognosis.  We called him the "medical miracle".  In the end, of course, the cancer won.  But Martin's attitude was truly admirable.  He accepted his diagnosis and was forthright with friends about the process of the illness and its treatment, all the while continuing to work and to enjoy his life.   

 

Meanwhile, Beth was beside him offering her support.  They were a team, Martin and Beth, and I know it's hard for her to imagine her life without him.  Because I grew up in Los Angeles where Duncan and I visited frequently, we would always stop to see Martin and Beth in Santa Monica and bask in their gracious hospitality.  Nothing fancy mind you, but they were always pleased to see us and to share a meal in the house or the backyard.  I have a fond memory of taking my elderly mother with us on one or two of these visits and seeing her entertained by Martin and Beth's friendly company.  Our world will be a lesser place without Martin; we will greatly miss his enthusiasm, energy, passion, wisdom and friendship.  Farewell, dear friend and colleague."- Dr. Maxine Stitzer

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

[#DIV28SUPER] In Memoriam: Dr. Martin Iguchi, Ph.D.

Dear Colleagues,

I am writing with the sad news that Dr. Martin Iguchi, Ph.D., a pillar in our Division and scientific community, passed away on Saturday June 5, 2021. Dr. Iguchi earned his PhD in experimental psychology from Boston University in 1986 and established himself as a major leader in our field over the past several decades. As his CV demonstrates, he led research in several impactful areas that included HIV research, treatment access for minority individuals, and expansion of care for persons with OUD and alcohol. His collective work spanned the spectrum from understanding mechanistic foundations of substance use to treatment implementation. Despite his strong science, Dr. Iguchi may have been equally well-known for being an exemplary scientific citizen. He has served in every capacity, including study sections, committee memberships, board of director and advisory board positions, and editorial roles. He also shared his wisdom through teaching, mentoring numerous junior scientists in predoctoral, post-doctoral, and early career roles, and his service on dissertation and promotion committees, earning awards for his prowess in this area. In recent years he had established himself as a policy leader who could be relied upon to help advocate for the advancement of research and care for persons with substance use disorder, producing a lasting legacy on our field.  

 

Dr. Iguchi was particularly committed to the work of APA and Division 28. He achieved Fellow status of our division in 2000 and was a fellow of Divisions 6, 9, and 50 as well.  He was the 2004 Division 28 Convention Chair, Member-at-Large for Division 50, member of the Board of Professional Affairs, member of an APA task force to make changes to the convention that would appeal to scientists, a member of the Board of Scientific Affairs, on the Health Disparities Steering Committee, on the Committee of Psychology of AIDS, and on the Board for the Advancement of Psychology in the Public Practice.  As a result of his profound contributions to the field, Dr. Iguchi was awarded an APA Presidential Citation in 2019 (a prestigious honor reserved for only a small number of outstanding psychologists).  

 

Dr. Iguchi was well-known at APA Consolidated Meetings as well as other professional organizational meetings, and always approached people with a smile and kind words. His welcoming demeanor and breadth of expertise made him an ideal ambassador for our science and his veracity in advocating for the use of science to advance public policy no doubt benefited countless numbers of patients and scientists. He represents the type of scientist we all aspire to become and will be dearly missed.  

More about his work is available here https://www.rand.org/about/people/i/iguchi_martin_y.html  and his APA Presidential citation is available here: https://www.apa.org/about/governance/president/citation/martin-iguchi

Please also see the following thoughts from our Divisional member and past President Dr. Maxine Stitzer

"I first met Martin Iguchi in the late 80's when he worked as a Postdoc at the BPRU on studies conducted in our methadone research clinic.  Over the years, he became a friend as well as a valued colleague and he will be sorely missed in both roles. Martin was enthusiastic, passionate, and optimistic about life.  He was diagnosed with metastatic colon cancer 5 years ago, and at that time, given a prognosis of one year.  He looked at the life he loved and chose to forge ahead.  He loved his work in addictions research and he loved his wife, Beth and their children Benjamin and Sarah.  He chose to pursue his research projects vigorously until he physically could no longer, contributing his wisdom to the important public health issues of the day and the research that underpins sensible policy.   

 

Maybe it was his positive attitude- these things are unknowable- but Martin beat the odds and stayed in this world, fighting his disease, for 5 long years after that first bleak prognosis.  We called him the "medical miracle".  In the end, of course, the cancer won.  But Martin's attitude was truly admirable.  He accepted his diagnosis and was forthright with friends about the process of the illness and its treatment, all the while continuing to work and to enjoy his life.   

 

Meanwhile, Beth was beside him offering her support.  They were a team, Martin and Beth, and I know it's hard for her to imagine her life without him.  Because I grew up in Los Angeles where Duncan and I visited frequently, we would always stop to see Martin and Beth in Santa Monica and bask in their gracious hospitality.  Nothing fancy mind you, but they were always pleased to see us and to share a meal in the house or the backyard.  I have a fond memory of taking my elderly mother with us on one or two of these visits and seeing her entertained by Martin and Beth's friendly company.  Our world will be a lesser place without Martin; we will greatly miss his enthusiasm, energy, passion, wisdom and friendship.  Farewell, dear friend and colleague."- Dr. Maxine Stitzer

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

[#DIV28SUPER] Research Coordinator Position at Johns Hopkins BPRU

Dear colleagues,

The Johns Hopkins University School of Medicine is seeking a full-time Research Program Coordinator at the Behavioral Pharmacology Research Unit (BPRU) within the Department of Psychiatry and Behavioral Sciences. The Research Program Coordinator would work closely with BPRU faculty and postdoctoral fellows to implement research in the clinical pharmacology of substance use including human laboratory and clinical research studies.

Areas of interest: The current opportunity would provide experience implementing multiple rigorous double-blind human laboratory drug administration studies among healthy volunteers including several substances of interest (e.g., caffeine/other stimulants, nicotine), as well as clinically-oriented research among substance use disorder patient populations.

Responsibilities and opportunity for growth: The Research Program Coordinator will oversee day-to-day activities of research projects including recruitment, screening, data collection and data management. The Research Program Coordinator will assist with the preparation of study reports, publications, and presentations. Many of our staff develop research skills at BPRU and go on to complete graduate work in psychology, medicine, or related disciplines.

Ideal candidate: Bachelor's degree in Psychology, Public Health, or any related field is required. Prior experience with human or nonhuman research is appropriate. Additional education may substitute for required experience and additional related experience may substitute for required education. The BPRU is particularly interested in candidates who can contribute to the diversity and excellence of our research program. Applications from persons with disabilities, protected veterans, underrepresented minorities, and women are strongly encouraged.

Start date: Immediate/Flexible.

To apply: Please contact Mary M. Sweeney, Ph.D. (msween19@jhmi.edu) and fill out the application through JHU jobs: https://jobs.jhu.edu/job/Baltimore-Research-Program-Coordinator-MD-21224/724456700/

Johns Hopkins University is an equal opportunity/affirmative action employer committed to recruiting, supporting, and fostering a diverse community.

Please do not hesitate to contact me with questions.

Best regards,

Maggie
________________________________________

Mary M. Sweeney, M.S., Ph.D.
Assistant Professor — Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Pronouns: she/her

[#DIV28SUPER] Free webinar (June 9, 5 EST) on The Role of Police in Overdose Response and Post-Overdose Outreach

Hello colleagues, 

Please consider attending a free webinar hosted by CPDD regarding the role of police in overdose response. The webinar is free to attend, and everyone will need to complete the free registration to access the talks. 

The webinar will be tomorrow, June 9th, from 5:00-6:00 pm.

More information and a link to registration is available here:

https://us02web.zoom.us/webinar/register/WN_RaUQb-mhRzysk953D6ACfw

Kelly Dunn, PhD, MBA

(Sent from my cell phone, please excuse typos).